Therapy Areas
30 January 2023 - Alpha Biopharma, a China-based developer of innovative drugs, announced on Sunday that the company's New Drug Application (NDA) for Zorifertinib, a next-generation EGFR-TKI, has been accepted by the Centre for Drug Evaluation (...
30 January 2023 - Loxo@Lilly, the oncology unit of US-based Eli Lilly and Company (NYSE: LLY), announced on Friday that the company has received approval for Jaypirca (pirtobrutinib, 100mg & 50mg tablets) from the US Food and Drug Administration....
30 January 2023 - Marengo Therapeutics, Inc., a US-based company involved in novel therapeutics targeting the T cell receptor (TCR) V-beta to selectively activate the right T cell subsets to fight cancer, announced on Friday that it has dosed its fir...
27 January 2023 - - The Europe human papillomavirus vaccine market is expected to grow from USD 1,202.66m in 2022 to USD 1,598.81m by 2028; it is estimated to grow at a CAGR of 4.9% from 2022 to 2028, according to a new report from Dublin-based Resea...
27 January 2023 - - The United States Food and Drug Administration has granted Fast Track Designation to tamibarotene for the treatment of higher-risk myelodysplastic syndrome (HR-MDS), US-based biopharmaceutical company Syros Pharmaceuticals, Inc. (...
27 January 2023 - Swedish research-based biopharma company BioArctic AB (STO:BIOA-B) reported on Friday that the European Medicines Agency (EMA) has accepted a marketing authorisation application (MAA) submitted by its partner Eisai Co Ltd (TYO:4523)...
26 January 2023 - - US-based bioinformatics and multi-omics company Universal Diagnostics (Universal DX) has posted the results of an international, observational cohort study which evaluated the effectiveness of utilizing a combination of cell-free ...